Detroit Man Takes $2.8 Million Gene Therapy Gamble at Henry Ford
Henry Ford Health gave the state’s first off‑trial infusion of ROCTAVIAN on Jan. 15, using a one‑time gene therapy that could replace years of costly prophylaxis. The treatment and its $2.8M+ drug price raise difficult trade‑offs for patients and payers.












